Neurocrine Biosciences Inc (NASDAQ:NBIX)
| 101.52 BATS BZX Real-Time Price As of 2:36pm ET |  -0.23 / -0.23%Today’s Change | 86.02 Today|||52-Week Range 136.26 | +5.92% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Gorman Kevin Charles Chief Executive Officer |  Sale | 1/08/2021 | 164,801 | $110.22 | $18.2M | -9.17% |
Gorman Kevin Charles Chief Executive Officer | Sale | 1/08/2021 | 143,449 | $110.21 | $15.8M | -9.17% |
Lippoldt Darin M Chief Legal Officer | Sale | 2/09/2021 | 30,000 | $116.16 | $3.5M | -11.95% |
Benevich Eric S Chief Commercial Officer | Sale | 11/02/2020 | 20,595 | $96.53 | $2.0M | +6.05% |
Gorman Kevin Charles Chief Executive Officer |  Buy | 1/08/2021 | 164,801 | $8.65 | $1.4M | -9.17% |
Gorman Kevin Charles Chief Executive Officer | Buy | 1/08/2021 | 143,449 | $8.66 | $1.2M | -9.17% |
Lippoldt Darin M Chief Legal Officer | Buy | 2/09/2021 | 30,000 | $35.99 | $1.1M | -11.95% |
Lloyd Smith Malcolm Chief Regulatory Officer | Sale | 1/25/2021 | 8,958 | $119.95 | $1.1M | -14.75% |
Lyons Gary A Director | Sale | 6/10/2021 | 10,000 | $100.27 | $1.0M | +1.27% |
Benevich Eric S Chief Commercial Officer | Buy | 11/02/2020 | 20,595 | $35.99 | $741.2K | +6.05% |
Page of 10